A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C

Hepatic fibrosis

Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis A Study of Experimental Medication BMS-986036 Given to Healthy Participants Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study